Home > Boards > US OTC > Biotechs > BioVie Inc. (BIVID)

I honestly didn't think .05s would hit but

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
ejobkar Member Profile
 
Followed By 0
Posts 73
Boards Moderated 0
Alias Born 03/05/12
160x600 placeholder
ejobkar   Sunday, 09/15/19 07:23:49 PM
Re: someconcerns post# 676
Post # of 725 
I honestly didn't think .05s would hit but its a great time to buy the weakness! The bid sizes are increasing (200k+) in the .05 range recently, so it won't be long until we push up again.


Per Tailwinds...

BioVie (BIVI): September and October portend to be an important months for BioVie. The Company should be filing their protocols with the FDA for the upcoming phase 2b/3 trial. After which, they are likely tapping the markets for $15M simultaneous with a reverse split and an uplisting to Nasdaq. The drug works and should be able to gain approval. The stock is cheap and the CEO, Terren Peizer, is a smart investor who owns a large majority of the Company. I’ll be increasing my position when they complete the financing and maybe even somewhat in advance if the stock stays weak.


https://tailwindsresearch.com/2019/09/fall-investor-preview-along-with-a-belated-august-recap/

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist